🤔 This week: TSLA Q3 earnings report - is now the right time to buy the EV giant?Explore TSLA Data

Stifel starts Amdocs coverage with Buy rating, sets $100 target

EditorLina Guerrero
Published 10/01/2024, 04:31 PM
© Amdocs PR
DOX
-

On Tuesday, Stifel began coverage on Amdocs Ltd. (NASDAQ:DOX), a software-led services business, assigning the stock a Buy rating and setting a price target of $100. Amdocs, historically known for providing Revenue Management Solutions to Telecom providers, has expanded its product offerings to cover a comprehensive range of services required by Communications Service Providers (CSPs) for customer management.

The firm highlighted Amdocs as a total return story, emphasizing the company's strategy to deliver an approximate 10% return to investors through a mix of earnings per share (EPS) growth and dividend yield. Stifel's valuation reflects confidence in Amdocs' ability to continue its trajectory of financial performance and shareholder returns.

Amdocs has evolved over the years, building a portfolio of solutions that span the entire customer service process for CSPs, from the front-end to the back-end. This expansion has positioned the company to meet the growing and changing needs of the telecommunications industry.

The price target of $100 set by Stifel suggests an optimistic outlook on the stock's potential for capital appreciation. Amdocs' commitment to both growth and dividends aligns with the investment firm's criteria for a stock that can provide a balanced return to investors.

Stifel's initiation of coverage on Amdocs with a Buy rating and a robust price target reflects a positive view on the company's future performance in the market. The firm anticipates that Amdocs' comprehensive product suite and focus on returns will continue to drive the company's success and appeal to investors.

In other recent news, Amdocs Limited reported robust Q3 results, marking a record revenue of $1.25 billion, a nearly 2% increase from the previous year. The company also highlighted a record-setting 12-month backlog of $4.25 billion and is projected to achieve its fiscal year 2024 guidance with expected revenue and non-GAAP diluted EPS growth of about 9%. Significant cloud solution deals were inked with AT&T, TELUS, and VodafoneZiggo, further bolstering the company's strong demand for cloud solutions.

Amdocs' progress in generative AI includes a partnership with a leading global operator. The company's cloud-related activities, which accounted for over 20% of total revenue last year, are expected to see double-digit growth in fiscal 2024. In terms of sustainability, Amdocs has reduced its CO2 emissions by 55% since fiscal 2019 and was recognized as one of the world's most sustainable companies by Time Magazine.

Despite macroeconomic pressures impacting growth rates, Amdocs maintains its guidance for constant currency revenue growth and non-GAAP diluted earnings per share growth for fiscal 2024. The full impact of a significant deal with AT&T is expected to be reflected in mid-2025. While the company faces challenges in achieving historical growth rates, it remains open to both accelerated buybacks and M&A opportunities. These are the latest developments for Amdocs Limited.

InvestingPro Insights

Stifel's optimistic outlook on Amdocs Ltd. (NASDAQ:DOX) aligns with several key metrics and insights from InvestingPro. The company's market cap stands at $9.99 billion, with a P/E ratio of 20.11, indicating a reasonable valuation for a company in the software and services sector.

InvestingPro Tips highlight Amdocs' commitment to shareholder returns, which supports Stifel's characterization of DOX as a "total return story." The company has been aggressively buying back shares and boasts a high shareholder yield. Moreover, Amdocs has raised its dividend for 12 consecutive years, demonstrating a strong track record of increasing shareholder value.

The company's financial health appears solid, with InvestingPro Data showing a revenue of $4.98 billion in the last twelve months as of Q3 2024, and a gross profit margin of 35.22%. This financial stability underpins Amdocs' ability to continue its growth trajectory and maintain its dividend policy, as emphasized in Stifel's analysis.

Interestingly, while Stifel has set a price target of $100, InvestingPro's Fair Value estimate stands even higher at $106.14, suggesting potential upside beyond Stifel's projections. This aligns with the stock's current price being 93.03% of its 52-week high, indicating room for growth.

For investors seeking more comprehensive insights, InvestingPro offers additional tips and metrics that could further inform investment decisions on Amdocs Ltd.

This article was generated with the support of AI and reviewed by an editor. For more information see our T&C.

Latest comments

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.